title: Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors.
abstract: The objectives of the study are to evaluate the prevalence and the associated factors of thought disorders in a large cross-sectional population of non-demented out patients with Parkinson's disease (PD). Four-hundred and nineteen consecutive non-demented PD patients were studied through the DoPaMiP cross-sectional study. Demographic and clinical variables were recorded, including motor and cognitive status, dependency, depressive and anxious symptoms, dysautonomia and sleep disorders. The presence of thought disorders over the past 15 days was assessed by the Unified Parkinson's Disease Rating Scale part I. Patients with and without thought disorders were compared using parametric tests. Logistic regression was applied to significant data. Thought disorders were present in 105 patients (25%) including vivid dreams in 83 (19.8%), benign hallucinations in 17 (4.1%), and hallucinations without insight in 5 (1.2%). No patient had delusion. Patients with thought disorders were more dependent than the others. Thought disorders were associated with longer PD duration, greater UPDRS scores and the presence of motor complications. Conversely, UPDRS tremor sub-score was lower in patients without thought disorders. Thought disorders were also associated with dysautonomia, lower MMSE score, depression and sleep disorders. Logistic regression identified PD duration, lower MMSE score, depressive and dysautonomic signs as independent risk factors. In conclusion, mild thought disorders were present in 25% of non-demented outpatients with PD, but hallucinations were present in 5% only. Thought disorders were associated with PD duration, depressive and dysautonomic symptoms and lower MMSE score.
authors.affiliation: Department of Neurosciences, University Hospital, Toulouse, France.
authors.forename: Rachel
authors.initials: R
authors.lastname: Debs
authors.forename: Valérie
authors.initials: V
authors.lastname: Cochen De Cock
authors.forename: Laurence
authors.initials: L
authors.lastname: Nègre-Pagès
authors.forename: Marina
authors.initials: M
authors.lastname: Aristin
authors.forename: Anna
authors.initials: A
authors.lastname: Senard
authors.forename: Olivier
authors.initials: O
authors.lastname: Rascol
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D008875:Middle Aged; D010300:Parkinson Disease / Q000453:epidemiology* / Q000523:psychology; D015995:Prevalence; D012307:Risk Factors
references.citation: Neurology. 1997 Aug;49(2):393-9
references.pmid: 9270567
references.citation: Brain. 2007 Jul;130(Pt 7):1787-98
references.pmid: 17535834
references.citation: Mov Disord. 1999 Jan;14(1):117-21
references.pmid: 9918353
references.citation: J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):727-33
references.pmid: 11385004
references.citation: Mov Disord. 2008 Mar 15;23(4):484-500
references.pmid: 18175343
references.citation: Mov Disord. 2006 Dec;21(12):2110-5
references.pmid: 17013922
references.citation: Am J Ophthalmol. 2000 Aug;130(2):261-2
references.pmid: 11004314
references.citation: Brain. 2007 Aug;130(Pt 8):2123-8
references.pmid: 17586867
references.citation: Neurology. 2009 Nov 3;73(18):1469-77
references.pmid: 19884574
references.citation: Arch Neurol. 1996 Dec;53(12):1265-8
references.pmid: 8970453
references.citation: Neurology. 2000 Jul 25;55(2):281-8
references.pmid: 10908906
references.citation: Neurology. 1995 Apr;45(4):669-71
references.pmid: 7723953
references.citation: Mov Disord. 2003 Jul;18(7):812-7
references.pmid: 12815661
references.citation: Psychiatry Res. 1989 May;28(2):193-213
references.pmid: 2748771
references.citation: Mov Disord. 2007 Jul 30;22(10):1510-1514
references.pmid: 17516497
references.citation: Neurology. 2005 Jan 11;64(1):81-6
references.pmid: 15642908
references.citation: Pain Suppl. 1986;3:S1-226
references.pmid: 3461421
references.citation: Arch Neurol. 1999 May;56(5):595-601
references.pmid: 10328255
references.citation: Sleep Med. 2008 Jul;9(5):473-4
references.pmid: 18024175
references.citation: Brain. 2009 Nov;132(Pt 11):2947-57
references.pmid: 19759203
references.citation: JAMA. 1969 May 19;208(7):1168-70
references.pmid: 5818715
references.citation: Neurology. 1993 Nov;43(11):2227-9
references.pmid: 8232934
references.citation: J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):734-8
references.pmid: 11385005
references.citation: Mov Disord. 2005 Nov;20(11):1439-48
references.pmid: 16028215
references.citation: Clin Neuropharmacol. 2002 Nov-Dec;25(6):318-24
references.pmid: 12469006
references.citation: Age Ageing. 1997 Sep;26(5):353-7
references.pmid: 9351479
references.citation: Neurology. 1997 Sep;49(3):724-8
references.pmid: 9305331
references.citation: Ann Neurol. 1993 Nov;34(5):710-4
references.pmid: 8239565
references.citation: Mov Disord. 2008 Jul 30;23(10):1361-9
references.pmid: 18546344